First anthrax vaccine developed using recombinant DNA technology- Annual production capacity of up to 10 million doses at GC ...

An Australian biotech firm says it has successfully used precision fermentation to reproduce the most vital proteins in human ...

According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced that it has been granted usage rights to a significant block of ...

Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, today announces the appointment of Francis Van Parys as Chief Executive ...

EpiVax, Inc., with U.S. Food and Drug Administration (FDA) and CUBRC, Inc. (Buffalo, NY) scientist collaborators, announces the publication of a study titled "Immunogenicity Risk Assessment of Peptide ...

The global market for Human Vaccines was valued at US$46.9 Billion in 2024 and is projected to reach US$71.4 Billion by 2030, growing at a CAGR of 7.3% from 2024 to 2030. This comprehensive report ...

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has opined that ...

University of Arkansas System President Jay B. Silveria has named four finalists to be the next University of Arkansas for ...

Avatar: Fire & Ash stars Sam Worthington and Stephen Lang talked to us about how their characters have changed throughout the ...

Solid Biosciences has secured US FDA rare paediatric disease designation for SGT-212, its investigational gene therapy targeting FA.